Our Commitment to Safety and Transparency as We Study Our Investigational COVID-19 Vaccine Candidate
Learn More
Share
Media Center
Latest Press Releases
September 23, 2020
September 21, 2020
Photos, Videos, Infographics & More
J&J Fast Facts
Our Company
We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.
-
September 21, 2016Thank you for your interest in learning more about our company. We care about your questions and concerns.May 25, 2018Sign up for RSS Feed to keep you updated with latest news.
Social Media
-
RT @ClimateGroup: Global Director of Sustainability at @JNJNews, @PhilDahlin, opens our panel to discuss the intertwined issues of climate…JNJNews
-
RT @ClimateGroup: Paulette Frank, Worldwide Vice President of Environmental Health, Safety, and Sustainability, @JNJNews, shares an importa…JNJNews
-
JUST IN: #JNJ has announced the start of our Phase 3 clinical trial for our investigational #COVID19 vaccine candid… https://t.co/7bLWuMMaZEJNJNews
More From Johnson & Johnson
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.On the next episode of "The Road to a Vaccine," host Lisa Ling delves into how the pandemic is affecting parents, children and school staff. We sat down with one of the upcoming guests, school nurse Robin Cogan, to find out the most pressing questions on her mind—and those of moms and dads.Cancer. Diabetes. Autoimmune diseases. They're the common illnesses we have a better chance at fighting, thanks to Dr. Cantley's pioneering work. Learn more about his "magic molecule" research.
